LSC Webinars

  1. Early Developability Assessment For Antibody Based Therapeutics 5/7/2026

    Learn how an integrated developability and immunosafety toolbox can help de-risk multi-specific antibody development, improve candidate selection, and accelerate complex biologics toward the clinic.

  2. Enhancing Gene Editing Outcomes And Safety for Clinical Translation With Next Generation Vectors 5/6/2026

    Learn how streamlined vector backbones can improve efficiency, consistency, and expression durability when reliability matters most.

  3. Engineering Precision In Genetic Medicines 4/30/2026

    Precision genome editing strategies that balance specificity and potency through advanced engineering workflows, AI‑driven optimization, and tailored editor design for clinical genetic medicines.

  4. Using Full DEL Data To Improve Early Compound Decisions 4/29/2026

    High-throughput screens hold insights beyond individual hits. Examine a broader view of screening data that reveals structure–function patterns to guide smarter compound prioritization.

  5. From DNA To IND In As Little As 6 Months 4/27/2026

    Discover how an integrated, platform-driven CMC approach can accelerate your antibody program from DNA to IND in as little as six months while reducing risk and maintaining quality and regulatory alignment.

  6. Biologics Tech Transfer & Validation at Scale: A Better Path to GMP 4/24/2026

    Explore where tech transfer and validation commonly falter, and how disciplined execution helps teams maintain control through PPQ and beyond.

  7. Unlocking The Next Wave Of Cancer Vaccines 4/21/2026

    Discover how advanced ionizable LNP formulations and scalable manufacturing strategies can accelerate the development and clinical translation of personalized cancer vaccines.

  8. Where Sourcing Meets Science: Smarter Collaboration, Better Outcomes 4/20/2026

    See how collaboration-driven raw material control reduces variability, improves cell culture performance, and delivers measurable cost and productivity gains in biotherapeutic manufacturing.

  9. OneTeam™: Setting A New Standard for Biotech Program Visibility 4/15/2026

    An on‑demand session showing how integrated governance and real‑time data boost visibility, collaboration, and control in outsourced gene therapy development.

  10. Less Risk, More Speed -The New Blueprint For Bioconjugate Development 4/15/2026

    A fireside chat on how integrated development models reduce risk and accelerate bioconjugate timelines from discovery through GMP manufacturing.